BILL (NYSE:BILL – Get Free Report) had its price target raised by Oppenheimer from $75.00 to $83.00 in a research report issued to clients and investors on Friday. The firm currently has an “overweight” rating on the stock. Oppenheimer’s price objective would indicate a potential upside of 17.15% from the company’s current price. Other equities […]